Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mujeeb U Shad

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Human Psychopharmacology|March 31, 2026
Bupropion-Memantine Combination in the Treatment of Major Depressive Disorder and Treatment-Resistant DepressionJuan Miguel Riestra, Yaxel Levin-Carrion, Roshan Sutar, et al.
Psychopharmacology|August 25, 2025
The weight reducing effects of naltrexone-bupropion among obese psychiatric and non-psychiatric patients: a systematic reviewHafsah Alim Ur Rahman, Muhammad Ahmed Ali Fahim, Unaiza Naeem, et al.
Human Psychopharmacology|May 15, 2023
Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literatureMuhammad Youshay Jawad, Maurish Fatima, Umer Hassan, et al.
The Psychiatric Clinics of North America|December 3, 2014
The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's diseaseSimon Chiu, Michel A Woodbury-Fariña, Mujeeb U Shad, et al.
Journal of Dual Diagnosis|December 20, 2023
Integrative Pharmacology in the Treatment of Substance Use DisordersJack Donlon, Pooja Kumari, Sajoy P Varghese, et al.
Journal of Psychiatric Practice|October 2, 2024
Mobile Delivery Program to Prevent Relapse and Improve Functioning in Patients With Psychiatric DiseasesErin M Sanzone, Olivia Kam, Kaitlin E Sanzone, et al.
Clinical Drug Investigation|August 1, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsHoulin Hong, Jack Donlon, Martin Schaefer, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Human Psychopharmacology|March 31, 2026
Bupropion-Memantine Combination in the Treatment of Major Depressive Disorder and Treatment-Resistant DepressionJuan Miguel Riestra, Yaxel Levin-Carrion, Roshan Sutar, et al.
Psychopharmacology|August 25, 2025
The weight reducing effects of naltrexone-bupropion among obese psychiatric and non-psychiatric patients: a systematic reviewHafsah Alim Ur Rahman, Muhammad Ahmed Ali Fahim, Unaiza Naeem, et al.
Human Psychopharmacology|May 15, 2023
Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literatureMuhammad Youshay Jawad, Maurish Fatima, Umer Hassan, et al.
The Psychiatric Clinics of North America|December 3, 2014
The role of nutrient-based epigenetic changes in buffering against stress, aging, and Alzheimer's diseaseSimon Chiu, Michel A Woodbury-Fariña, Mujeeb U Shad, et al.
Journal of Dual Diagnosis|December 20, 2023
Integrative Pharmacology in the Treatment of Substance Use DisordersJack Donlon, Pooja Kumari, Sajoy P Varghese, et al.
Journal of Psychiatric Practice|October 2, 2024
Mobile Delivery Program to Prevent Relapse and Improve Functioning in Patients With Psychiatric DiseasesErin M Sanzone, Olivia Kam, Kaitlin E Sanzone, et al.
Clinical Drug Investigation|August 1, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsHoulin Hong, Jack Donlon, Martin Schaefer, et al.
Pageof 6